ArticleMolecular cancer therapeutics2009

Celecoxib antagonizes perifosine's anticancer activity involving a cyclooxygenase-2-dependent mechanism.

Heath A Elrod et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.